Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Intellectural Property Used to Create Scientific Software to Aid in Drug Design

06.09.2004


VeraChem LLC founders Drs. Michael Gilson, Michael Potter, and Hillary Gilson, using UMBI licensed intellectual property, are creating scientific software that provides expert users with tools for computer-aided drug discovery and molecular design. VeraChem’s recent first sale, a pre-release version of Vconf, is followed by the projected launch on September 8 of Vcharge, a new software product for computing molecular properties important in drug design. The official launch of Vconf is expected to follow later in 2004.

“Vcharge combines speed and accuracy in a unique software package that will be available for the Linux and Windows operating systems,” says Dr. Gilson, Chief Scientific Officer for VeraChem LLC and Professor at UMBI’s Center for Advanced Research in Biotechnology. “This product is just the first in a series that will bring advanced computational methods in an affordable and user-friendly format to experts in the pharmaceutical and biotechnology industries.”

“Vcharge is a tool for computer-aided drug design,” says Dr. Gilson. “It allows the designer to compute the atomic charges of a candidate drug molecule as a step in determining whether it will effectively bind a targeted protein. Most drugs work by binding tightly to a targeted protein molecule. For example, HIV protease inhibitors help patients by binding and blocking the function of a protein that the AIDS virus needs to survive and reproduce. Each atom of a protein carries a small electrical charge and, since opposite charges attract while like charges repel, it is important that the atoms of a drug molecule have charges which complement the targeted protein.”


In addition to Vcharge, the entrepreneurs at VeraChem have developed a proprietary software toolkit with a range of functionalities, including ligand-protein docking and scoring, powerful conformational search of candidate drug molecules, computation of atomic energies and forces, automatic generation of alternative resonance forms of drug-like compounds, and automatic detection of topological and 3d molecular symmetries. VeraChem also has developed a novel user-interface design that shortens the learning curve for high-end modeling technologies. These technologies will form the basis of a series of upcoming products.

“The creation of VeraChem, and the launch of its first niche market product, Vcharge, is a success for both UMBI and the principals of VeraChem, LLC,” says Dr. Jennie Hunter-Cevera, President of the University of Maryland Biotechnology Institute (UMBI). “Through VeraChem, UMBI licensed intellectual property has been put to good business use, enabling the creation of a marketable product that meets the needs of the scientific community, as well as furthering biotechnology research. Seasoned scientists, as well as those early on in their careers will be able to use this software to increase speed and accuracy. We are very proud of Dr. Gilson and the team of experts at VeraChem.”

For more information on Vcharge, or to place an order for this new scientific software, visit http://www.verachem.com. For more information on the Center for Advanced Research in Biotechnology, a cooperative venture with the National Institutes of Standards and Technology (NIST) and Montgomery County, Maryland, visit http://www.umbi.umd.edu and proceed to the About Us section.

| newswise
Further information:
http://www.umbi.umd.edu.
http://www.verachem.com

More articles from Life Sciences:

nachricht Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH

nachricht Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>